Serving as a field-based extension of the Company, the Medical Science Liaison (MSL) will represent the Company and their recently approved PCSK9 inhibitor, therapy indicated as an adjunct to diet and exercise: to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).
Duties And ResponsibilitiesSalary offers to be determined based on industry experience, education, and therapeutic expertise.
#J-18808-Ljbffr read more